HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $875,253 | +296.2% | 16,716 | +207.8% | 0.03% | +275.0% |
| Q1 2024 | $220,894 | +1.8% | 5,430 | -7.5% | 0.01% | 0.0% |
| Q4 2023 | $216,918 | -3.4% | 5,869 | -0.1% | 0.01% | -11.1% |
| Q3 2023 | $224,503 | +2.5% | 5,877 | -3.4% | 0.01% | 0.0% |
| Q2 2023 | $219,000 | -32.0% | 6,084 | -27.8% | 0.01% | -30.8% |
| Q1 2023 | $322,000 | -40.9% | 8,429 | -12.0% | 0.01% | -38.1% |
| Q4 2022 | $545,000 | +43.8% | 9,577 | -0.2% | 0.02% | +31.2% |
| Q3 2022 | $379,000 | -6.4% | 9,597 | +4.2% | 0.02% | 0.0% |
| Q2 2022 | $405,000 | +2.8% | 9,211 | -6.8% | 0.02% | +23.1% |
| Q1 2022 | $394,000 | +0.5% | 9,881 | +1.3% | 0.01% | +8.3% |
| Q4 2021 | $392,000 | -1.8% | 9,753 | -0.7% | 0.01% | -14.3% |
| Q3 2021 | $399,000 | -13.3% | 9,820 | -3.0% | 0.01% | -6.7% |
| Q2 2021 | $460,000 | -55.3% | 10,120 | -59.0% | 0.02% | -57.1% |
| Q1 2021 | $1,030,000 | -3.9% | 24,698 | -1.6% | 0.04% | -2.8% |
| Q4 2020 | $1,072,000 | +62.7% | 25,092 | +0.1% | 0.04% | +50.0% |
| Q3 2020 | $659,000 | -2.1% | 25,060 | -0.2% | 0.02% | -7.7% |
| Q2 2020 | $673,000 | +9.1% | 25,098 | -26.8% | 0.03% | +8.3% |
| Q1 2020 | $617,000 | +41.2% | 34,274 | +39.2% | 0.02% | +71.4% |
| Q4 2019 | $437,000 | -21.1% | 24,627 | -31.1% | 0.01% | -22.2% |
| Q3 2019 | $554,000 | -29.1% | 35,718 | -21.4% | 0.02% | -28.0% |
| Q2 2019 | $781,000 | +20.5% | 45,439 | +12.9% | 0.02% | +19.0% |
| Q1 2019 | $648,000 | +40.0% | 40,260 | +27.3% | 0.02% | +31.2% |
| Q4 2018 | $463,000 | -44.7% | 31,630 | -31.4% | 0.02% | -33.3% |
| Q3 2018 | $838,000 | +18.0% | 46,115 | +9.6% | 0.02% | -27.3% |
| Q2 2018 | $710,000 | – | 42,063 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |